Today: 27 June 2026
Alphabet Stock Faces $185 Billion AI Test as Earnings Put Google Cloud in Focus

Alphabet Stock Faces $185 Billion AI Test as Earnings Put Google Cloud in Focus

New York, April 27, 2026, 10:02 EDT

All eyes are on Alphabet’s earnings this week, as the company faces a major test of investor tolerance for its huge artificial intelligence outlays. The Google parent’s market value has surged above $4.17 trillion, with shares hovering just below record highs. Class A stock was last up 0.5% at $346.06 in early New York trading.

It’s a packed Wednesday: Microsoft, Alphabet, Amazon, and Meta each release earnings, and the market’s watching closely to see if ballooning AI and data-center investment continues to drive real growth, or just racks up expenses. This week also brings results from over a third of S&P 500 companies, which means Alphabet’s numbers will carry even more weight than usual.

Alphabet is on deck to release its first-quarter numbers after Wednesday’s close, with a conference call set for 4:30 p.m. Eastern. Options pricing flagged by Investopedia suggests traders are bracing for as much as a 5% swing in the shares this week. Visible Alpha’s forecasts peg revenue for the quarter at $106.97 billion, up 19% year-over-year, but see earnings per share dipping by 3 cents to $2.73 as spending on AI ticks higher.

At this point, investors aren’t wondering if Alphabet plans to spend—they’re watching to see how quickly those investments move the needle in Google Cloud and Search, and whether profits hold up in the process. Daniel Sparks at The Motley Fool zeroed in on two key metrics: earnings per share and Google Cloud’s annual revenue growth rate.

Cloud has moved front and center for Alphabet. In the fourth quarter, Google Cloud pulled in $17.7 billion in revenue, up 48%. Operating income jumped as well, hitting $5.3 billion—more than double. Back in February, Reuters noted Alphabet’s guidance: for 2026, capital spending is pegged between $175 billion and $185 billion, far above the $91.45 billion set for 2025, analysts heard at the time.

At last week’s Cloud Next, Google pressed its case: the spending is fueling scale. CEO Sundar Pichai pointed to direct customer API use, saying Google’s first-party models are now handling upwards of 16 billion tokens each minute—a token being a chunk of text an AI model processes or generates. Pichai added that for 2026, just over half of Alphabet’s planned machine-learning compute spend will flow into the cloud unit.

Pichai cut straight to the point: customers aren’t just wondering if it’s possible to build an agent anymore—they’re grappling with the challenge of managing thousands. To address that, Google rolled out the Gemini Enterprise Agent Platform, calling it “mission control for the agentic enterprise.” AI agents handle planning and execution, taking on tasks with minimal step-by-step direction from humans. blog.google

At the Las Vegas event, Google Cloud CEO Thomas Kurian didn’t mince words. “The experimental phase is behind us, and now the real challenge begins,” he told Reuters. Kurian said Vertex AI is no longer mostly about traditional machine-learning; the focus has moved, Reuters reported, to customers rushing to build their own custom AI agents. Reuters

The hardware side also got a spotlight. Google rolled out two new custom AI chips—eighth-generation Tensor Processing Units. The TPU 8t targets training hefty models, while the TPU 8i handles inference, churning out AI responses in real time. Both chips, Google said, are headed for general release later this year and will be part of its AI Hypercomputer stack.

Competition in the space isn’t getting any cheaper. According to Reuters, Google Cloud held 14% of the cloud market at the close of 2025—still trailing both Amazon and Microsoft. Alphabet is ramping up its bets on AI as well: Reuters reported Friday that Google has committed to invest as much as $40 billion in Anthropic, just a few days after Amazon announced plans for up to $25 billion in the Claude developer.

Most on Wall Street haven’t budged. Citi just bumped its Alphabet target up to $405 from $390, calling out Gemini engagement, ad sales, and Google Cloud as areas to watch, according to Investopedia. Out of 14 analysts tracked by Visible Alpha, 12 call the stock a buy. The group’s average target sits at $382.

There’s a catch: the spending could hit the books ahead of any real return. Alphabet’s CFO pointed out that depreciation jumped 38% to $21.1 billion in 2025, with expectations for it to pick up speed in the first quarter and “meaningfully increase” over the full year, The Motley Fool reported. Even with a solid cloud result, investors might balk if the AI push starts eating into earnings. The Motley Fool

So Alphabet has to thread the needle: Search needs to appear stable, Cloud has to pick up speed, and Gemini should start resembling a revenue engine instead of just an R&D project. Hit those notes, and that $185 billion AI budget might finally look like a moat. Miss, and it hangs overhead as a burden.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Wait 90 Days Before Buying More SpaceX Stock Due to Upcoming Share Unlocks
    June 27, 2026, 12:00 PM EDT. Space Exploration Technologies (SpaceX) recently made a record-breaking $75 billion initial public offering (IPO), valuing the company at $1.77 trillion. Although its stock briefly surged, it has dropped 3% since debut. Investors should consider waiting 90 days before buying more shares due to an upcoming lockup period, during which insiders are restricted from selling. After this period, additional shares will enter the market, potentially pressuring the stock price downward. SpaceX only floated about 4% of shares initially, with gradual increases expected over time. Historically, blockbuster IPOs often underperform in their first years, so patience and reassessment after the lockup expiration in September is advised to gauge true market response and valuation.

Latest articles

PayPal stock surge shifts short-interest story into next week

PayPal stock surge shifts short-interest story into next week

27 June 2026
PayPal surged 4.5% to $44.29 Friday on trading volume more than double its 65-day average, following a 9.7% jump in short interest to 54.35 million shares as of June 15, equal to 6.2% of float; despite the rally, shares remain 44% below last year’s high, with the stock still seen as a turnaround play and a shortened trading week ahead due to the July 3 U.S. holiday.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus
Previous Story

Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus

Dow Jones Today: Oil Spike, Fed Week and Big Tech Earnings Put Rally on Edge
Next Story

Dow Jones Today: Oil Spike, Fed Week and Big Tech Earnings Put Rally on Edge

Go toTop